Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...

Getting the annual RSV shot and other important vaccines is a fantastic way to safeguard yourself and your family as winter ...

The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...

Image by Arek Socha from Pixabay November 12, 2024 - By Lorna Fernandes - As fall arrives, so does respiratory syncytial ...

At the moment, there is no FDA-approved vaccine for RSV, a common viral infection that ... aged 60 or over were randomised to a single 120 μg dose of the shot or a matched placebo.

RSV vaccines effective, but more people need to get them Date: October 28, 2024 Source: University of Rochester Medical Center Summary: Doctors detail what we learned after the first season ...

It’s time for the provincial government to stop dragging its heels on paying for a pair of injections that can protect the ...

Recruitment is underway for a clinical trial testing a vaccine candidate produced with The University of Queensland's molecular clamp technology against life-threatening respiratory viruses.

All RSV vaccines are currently given as a single dose ... For the COVID vaccines, the full price is about $120. If you don’t ...

A global real-world study of the vaccine for respiratory syncytial virus (RSV) finds it offers folks aged 60 and over 80% protection against severe illness and/or hospitalization. With U.S ...

In years prior to the availability of an RSV vaccine, an estimated 60,000 to 160,000 RSV-associated hospitalizations and 6,000 to 10,000 RSV-associated deaths occurred annually among U.S. adults ...

In clinical studies, the Arexvy vaccine against RSV provided good protection against ... falling to 57% by 120-180 days. The evaluation is only based on adults aged 65 and over who were eligible ...